Denali Therapeutics Inc.
MODULATORS OF EUKARYOTIC INITIATION FACTOR 2

Last updated:

Abstract:

The present disclosure relates generally to eukaryotic initiation factor 2B modulators of formula A, or a pharmaceutically acceptable salt, stereoisomer, or mixture of stereoisomers thereof and methods of making and using thereof. ##STR00001##

Status:
Application
Type:

Utility

Filling date:

22 Mar 2019

Issue date:

6 May 2021